Palmitoylation-driven PHF2 ubiquitination and degradation reduce the destruction of SREBP1c, thereby increasing SREBP1c-dependent lipogenesis and the malignant progression of HCC.331. The gene discussed is SREBF1; the disease is hepatocellular carcinoma.